| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |